Logo image of PGY

PAGAYA TECHNOLOGIES LTD -A (PGY) Stock Fundamental Analysis

NASDAQ:PGY - Nasdaq - IL0011858912 - Common Stock - Currency: USD

23.49  -0.2 (-0.84%)

Premarket: 23.76 +0.27 (+1.15%)

Fundamental Rating

3

Overall PGY gets a fundamental rating of 3 out of 10. We evaluated PGY against 282 industry peers in the Software industry. PGY may be in some trouble as it scores bad on both profitability and health. PGY is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year PGY has reported negative net income.
In the past year PGY had a positive cash flow from operations.
In the past 5 years PGY reported 4 times negative net income.
Of the past 5 years PGY 4 years had a positive operating cash flow.
PGY Yearly Net Income VS EBIT VS OCF VS FCFPGY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

PGY has a worse Return On Assets (-29.16%) than 73.76% of its industry peers.
PGY has a worse Return On Equity (-90.98%) than 76.24% of its industry peers.
PGY has a Return On Invested Capital of 7.82%. This is amongst the best in the industry. PGY outperforms 80.14% of its industry peers.
Industry RankSector Rank
ROA -29.16%
ROE -90.98%
ROIC 7.82%
ROA(3y)-23.94%
ROA(5y)-18.43%
ROE(3y)-59.08%
ROE(5y)-43.26%
ROIC(3y)N/A
ROIC(5y)N/A
PGY Yearly ROA, ROE, ROICPGY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

PGY's Operating Margin of 9.92% is fine compared to the rest of the industry. PGY outperforms 75.89% of its industry peers.
PGY has a worse Gross Margin (42.44%) than 73.76% of its industry peers.
PGY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.92%
PM (TTM) N/A
GM 42.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.22%
GM growth 5YN/A
PGY Yearly Profit, Operating, Gross MarginsPGY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 -40

2

2. Health

2.1 Basic Checks

PGY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, PGY has more shares outstanding
PGY has a worse debt/assets ratio than last year.
PGY Yearly Shares OutstandingPGY Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M 200M
PGY Yearly Total Debt VS Total AssetsPGY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

PGY has an Altman-Z score of 1.47. This is a bad value and indicates that PGY is not financially healthy and even has some risk of bankruptcy.
PGY has a Altman-Z score (1.47) which is in line with its industry peers.
PGY has a debt to FCF ratio of 10.98. This is a negative value and a sign of low solvency as PGY would need 10.98 years to pay back of all of its debts.
PGY's Debt to FCF ratio of 10.98 is in line compared to the rest of the industry. PGY outperforms 49.65% of its industry peers.
PGY has a Debt/Equity ratio of 1.24. This is a high value indicating a heavy dependency on external financing.
PGY has a worse Debt to Equity ratio (1.24) than 77.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 10.98
Altman-Z 1.47
ROIC/WACC0.83
WACC9.39%
PGY Yearly LT Debt VS Equity VS FCFPGY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.79 indicates that PGY should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.79, PGY is in line with its industry, outperforming 56.03% of the companies in the same industry.
PGY has a Quick Ratio of 1.79. This is a normal value and indicates that PGY is financially healthy and should not expect problems in meeting its short term obligations.
PGY has a Quick ratio (1.79) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.79
PGY Yearly Current Assets VS Current LiabilitesPGY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

6

3. Growth

3.1 Past

The earnings per share for PGY have decreased strongly by -217.73% in the last year.
Looking at the last year, PGY shows a very strong growth in Revenue. The Revenue has grown by 23.69%.
Measured over the past years, PGY shows a very strong growth in Revenue. The Revenue has been growing by 29.57% on average per year.
EPS 1Y (TTM)-217.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%309.09%
Revenue 1Y (TTM)23.69%
Revenue growth 3Y29.57%
Revenue growth 5YN/A
Sales Q2Q%18.23%

3.2 Future

Based on estimates for the next years, PGY will show a very strong growth in Earnings Per Share. The EPS will grow by 36.40% on average per year.
The Revenue is expected to grow by 15.94% on average over the next years. This is quite good.
EPS Next Y142.63%
EPS Next 2Y58.57%
EPS Next 3Y36.4%
EPS Next 5YN/A
Revenue Next Year21.11%
Revenue Next 2Y17.94%
Revenue Next 3Y15.94%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PGY Yearly Revenue VS EstimatesPGY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
PGY Yearly EPS VS EstimatesPGY Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 2 -2 -4

6

4. Valuation

4.1 Price/Earnings Ratio

PGY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 8.30, the valuation of PGY can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PGY indicates a rather cheap valuation: PGY is cheaper than 93.97% of the companies listed in the same industry.
PGY's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.34.
Industry RankSector Rank
PE N/A
Fwd PE 8.3
PGY Price Earnings VS Forward Price EarningsPGY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PGY indicates a rather cheap valuation: PGY is cheaper than 85.82% of the companies listed in the same industry.
74.11% of the companies in the same industry are more expensive than PGY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 30.34
EV/EBITDA 16.32
PGY Per share dataPGY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PGY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PGY's earnings are expected to grow with 36.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.57%
EPS Next 3Y36.4%

0

5. Dividend

5.1 Amount

No dividends for PGY!.
Industry RankSector Rank
Dividend Yield N/A

PAGAYA TECHNOLOGIES LTD -A

NASDAQ:PGY (7/15/2025, 8:13:52 PM)

Premarket: 23.76 +0.27 (+1.15%)

23.49

-0.2 (-0.84%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-07 2025-08-07/bmo
Inst Owners58.82%
Inst Owner Change0%
Ins Owners1.76%
Ins Owner Change-40.45%
Market Cap1.78B
Analysts84.29
Price Target22.98 (-2.17%)
Short Float %17.14%
Short Ratio3.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-559.07%
Min EPS beat(2)-1261.55%
Max EPS beat(2)143.41%
EPS beat(4)1
Avg EPS beat(4)-2922.83%
Min EPS beat(4)-10197%
Max EPS beat(4)143.41%
EPS beat(8)1
Avg EPS beat(8)-1567.88%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.84%
Min Revenue beat(2)0.72%
Max Revenue beat(2)2.96%
Revenue beat(4)4
Avg Revenue beat(4)1.97%
Min Revenue beat(4)0.58%
Max Revenue beat(4)3.6%
Revenue beat(8)7
Avg Revenue beat(8)1.91%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.23%
PT rev (3m)4.31%
EPS NQ rev (1m)1.19%
EPS NQ rev (3m)129.91%
EPS NY rev (1m)72.9%
EPS NY rev (3m)45.05%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)3.79%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.3
P/S 1.65
P/FCF 30.34
P/OCF 22.1
P/B 4.34
P/tB 4.74
EV/EBITDA 16.32
EPS(TTM)-4.48
EYN/A
EPS(NY)2.83
Fwd EY12.05%
FCF(TTM)0.77
FCFY3.3%
OCF(TTM)1.06
OCFY4.53%
SpS14.22
BVpS5.41
TBVpS4.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.16%
ROE -90.98%
ROCE 9.9%
ROIC 7.82%
ROICexc 9.45%
ROICexgc 9.83%
OM 9.92%
PM (TTM) N/A
GM 42.44%
FCFM 5.44%
ROA(3y)-23.94%
ROA(5y)-18.43%
ROE(3y)-59.08%
ROE(5y)-43.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.22%
GM growth 5YN/A
F-Score4
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 10.98
Debt/EBITDA 3.71
Cap/Depr 72.51%
Cap/Sales 2.03%
Interest Coverage 250
Cash Conversion 58.75%
Profit Quality N/A
Current Ratio 1.79
Quick Ratio 1.79
Altman-Z 1.47
F-Score4
WACC9.39%
ROIC/WACC0.83
Cap/Depr(3y)180.79%
Cap/Depr(5y)346.68%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-217.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%309.09%
EPS Next Y142.63%
EPS Next 2Y58.57%
EPS Next 3Y36.4%
EPS Next 5YN/A
Revenue 1Y (TTM)23.69%
Revenue growth 3Y29.57%
Revenue growth 5YN/A
Sales Q2Q%18.23%
Revenue Next Year21.11%
Revenue Next 2Y17.94%
Revenue Next 3Y15.94%
Revenue Next 5YN/A
EBIT growth 1Y1192.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year443.62%
EBIT Next 3Y80.94%
EBIT Next 5YN/A
FCF growth 1Y167.16%
FCF growth 3Y0.07%
FCF growth 5YN/A
OCF growth 1Y232.26%
OCF growth 3Y10.12%
OCF growth 5YN/A